Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors

被引：16
|
作者：
Gravani, A. [1 ]
Gaitanis, G. [1 ]
Tsironi, T. [1 ]
Tigas, S. [2 ]
Bassukas, I. D. [1 ]
机构：
[1] Univ Ioannina, Sch Hlth Sci, Dept Skin & Venereal Dis, Fac Med, Ioannina, Greece
[2] Univ Ioannina, Sch Hlth Sci, Dept Endocrinol, Fac Med, Ioannina, Greece
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2018年 / 32卷 / 12期
关键词：
D O I：
10.1111/jdv.14957
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E438 / E439
页数：2
相关论文
共 50 条
  • [1] Commentary on 'Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors'
    Fania, L.
    Di Zenzo, G.
    Mazzanti, C.
    Abeni, D.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (12) : E439 - E440
  • [2] Prevalence of diabetes mellitus in bullous pemphigoid patients in the absence of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis
    William Guo
    Sourish Rathi
    Jocellie Marquez
    Holly Smith
    Annet Kuruvilla
    Marcia G. Tonnesen
    Joann N. Salvemini
    [J]. Archives of Dermatological Research, 2023, 315 : 2207 - 2213
  • [3] Prevalence of diabetes mellitus in bullous pemphigoid patients in the absence of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis
    Guo, William
    Rathi, Sourish
    Marquez, Jocellie
    Smith, Holly
    Kuruvilla, Annet
    Tonnesen, Marcia G.
    Salvemini, Joann N.
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (08) : 2207 - 2213
  • [4] Bullous pemphigoid with dipeptidyl peptidase-4 inhibitors: Clinical features and pathophysiology
    Murakami, Takaaki
    Yabe, Daisuke
    Inagaki, Nobuya
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (05) : 1168 - 1170
  • [5] Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: the importance of the pharmacotherapeutic history
    Fernando Garcia-Gil, Miguel
    Lezcano Biosca, Victoria
    Garcia Garcia, Mar
    Monte Serrano, Juan
    Aldea Manrique, Beatriz
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1143) : 51 - 52
  • [6] A Case Report of Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors
    Aouidad, Iman
    Fite, Charlotte
    Marinho, Eduardo
    Deschamps, Lydia
    Crickx, Beatrice
    Descamps, Vincent
    [J]. JAMA DERMATOLOGY, 2013, 149 (02) : 243 - 245
  • [7] Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid: A comparative study of 100 patients with bullous pemphigoid and diabetes mellitus
    Chanprapaph, Kumutnart
    Pratumchart, Nathathai
    Limtong, Preeyachat
    Rutnin, Suthinee
    Sukasem, Chonlaphat
    Kungvalpivat, Pintusorn
    Triamchaisri, Siripich
    Suchonwanit, Poonkiat
    [J]. JOURNAL OF DERMATOLOGY, 2021, 48 (04): : 486 - 496
  • [8] Dipeptidyl peptidase-4 inhibitors and the risk of bullous pemphigoid among patients with type 2 diabetes
    Rouette, Julie
    Douros, Antonios
    Yin, Hui
    Yu, Oriana Hoi Yun
    Filion, Kristian B.
    Azoulay, Laurent
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB47 - AB47
  • [9] Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases
    Yoshiji, Satoshi
    Murakami, Takaaki
    Harashima, Shin-ichi
    Ko, Rie
    Kashima, Riko
    Yabe, Daisuke
    Ogura, Masahito
    Doi, Kentaro
    Inagaki, Nobuya
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (02) : 445 - 447
  • [10] Co-medications and dipeptidyl peptidase-4 inhibitors associated bullous pemphigoid
    Gravani, Agoritsa
    Christou, Panagiota
    Tigas, Stelios
    Bassukas, Ioannis D.
    [J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2021, 96 (06) : 782 - 784
12345